PL
Peter Lawson Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $405 |
51%
upside
| 3 | -4.4% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $22 |
19%
upside
| 1 | +74% |
0
%
| 4 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $101 |
1%
downside
| 1 | +1.6% |
0
%
| 29 Oct ‘25 7 months ago |
|
|
|
Overweight
Initiated
| $40 |
32%
upside
| 1 | +34% |
0
%
| 4 Sep ‘25 9 months ago |
|
|
|
Overweight
Initiated
| $25 |
71%
upside
| 1 | -36% |
0
%
| 14 Aug ‘25 10 months ago |
|
|
|
Equal-Weight
Downgraded
| $3 |
67%
downside
| 1 | – |
–
| 23 Jul ‘25 10 months ago |
|
|
|
Equal-Weight
Maintained
| $40 |
25%
downside
| 1 | – |
–
| 10 Jul ‘25 11 months ago |
|